Additionally, the expression of phospho-p90RSK measured by western blotting and immunohistochemistry in human breast cancer tissue was associated with the response to neoadjuvant chemotherapy in locally advanced breast cancer. This evidence concerns the gene RPS6KA1 and breast cancer.